Home›Screener›DRTS›Profile
F
26/100

Alpha Tau Medical Ltd.

DRTSBiotech / Pharma
← Signals View
Analyst Summary
✓ VERIFIED2026-06-17

Alpha Tau Medical Ltd. (DRTS) is the lead sponsor of 17 active clinical trials listed on ClinicalTrials.gov[1].

DRTS has 1 Form 4 insider filing recorded at the SEC in the past 30 days[2].

Sources

  1. ClinicalTrials.gov (2026-06-17) ↗
  2. SEC EDGAR · 0001871321 (2026-06-17) ↗
Clinical Trials
17
NCT03737734Skin Cancer, Mucosal Neoplasm of Oral Cavity, Soft Tissue Neoplasm
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT03889899Skin Cancer, Mucosal Neoplasm of Oral Cavity, Soft Tissue Neoplasm
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT04002479Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT04068155Skin Cancer, Cutaneous Tumor, Cutaneous Metastasis
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT04534127Skin Cancer, Mucosal Neoplasm of Oral Cavity, Soft Tissue Neoplasm
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT05047094Head and Neck Squamous Cell Carcinoma, Skin Cancer, Metastatic Head-and-neck Squamous-cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT05323253Recurrent Squamous Cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT05632913Recurrent Lung Cancer, Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT05657743Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT05781555Malignant Tumor
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT05829291Liver Metastases
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT06026943Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT06202118Breast Cancer, Recurrent Breast Cancer, Breast Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT06202248Non-metastatic Prostate Cancer, Locally Recurrent Prostate Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT06615635Squamous Cell Carcinoma, Alpha Radiation, Immunocompromised, Carcinoma, Squamous, Skin Cancer, Brachytherapy
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT06698458Pancreatic Cancer, Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
NCT06910306Recurrent Glioblastoma, Recurrent Gliomas
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
Insider Activity
1
1 filing
Source ↗
sec_edgar · Retrieved 2026-06-17
Not financial advice. BiotechSign profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-212026-07-18
Signal Summary
PDUFA Dates0
Insider Filings1
Clinical Trials1
Sector Peers (Biotech / Pharma)
GRIGRI Bio, Inc.
A
SUPNSupernus Pharmaceuticals, Inc.
B
EIKNEikon Therapeutics, Inc.
B
CADLCandel Therapeutics, Inc.
B
CMPXCompass Therapeutics, Inc.
B
Data Provenance
cik1 verified
clinical trial17 verified
insider buy1 verified
trial count1 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR